Association of Metformin With the Development of Age-related Macular Degeneration in the Diabetes Prevention Program Outcomes Study-Reply
- PMID: 37227711
- PMCID: PMC11371414
- DOI: 10.1001/jamaophthalmol.2023.1892
Association of Metformin With the Development of Age-related Macular Degeneration in the Diabetes Prevention Program Outcomes Study-Reply
Conflict of interest statement
Comment on
-
Association of Metformin With the Development of Age-Related Macular Degeneration.JAMA Ophthalmol. 2023 Feb 1;141(2):140-147. doi: 10.1001/jamaophthalmol.2022.5567. JAMA Ophthalmol. 2023. PMID: 36547967 Free PMC article.
-
Association of Metformin With the Development of Age-Related Macular Degeneration in the Diabetes Prevention Program Outcomes Study.JAMA Ophthalmol. 2023 Jul 1;141(7):696. doi: 10.1001/jamaophthalmol.2023.1889. JAMA Ophthalmol. 2023. PMID: 37227707 No abstract available.
References
-
- Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866–875. doi:10.1016/S2213-8587(l5)00291-0 - DOI - PMC - PubMed
-
- Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. a case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000;107(12):2224–2232. doi:10.1016/S0161-6420(00)00409-7 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
